AstraZeneca, Pfizer and more are leveraging the computational power of AI to better design trials, predict the potential ...

While cancelled NIH grants and regulatory uncertainty are less hospitable to clinical research in the U.S., Europe must play ...

The FDA’s Oncologic Drugs Advisory Committee narrowly voted against the approval of Zusduri, citing the lack of a completely ...

Friday’s deal with fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in China.

Martin Kulldorff and Robert Malone, both outspoken vaccine skeptics, have received compensation for their expert ...

The rehired staff, who number around 460, work with the CDC’s viral disease prevention efforts and sexual health testing labs ...

Scientists and analysts express concern that the newly appointed members—which include known anti-vaxxers—could relitigate ...

The biopharma job market failed to turn around in May, but employers were still hiring, especially in Indiana and California, ...

In what Guggenheim Partners called one of Metsera’s “critical program milestones” this year, its ultra-long-acting amylin ...

Looking for a new opportunity in New Jersey? These nine companies have open roles that could be a great fit for you.

The eight new committee members replace the 17 Kennedy removed earlier this week. In “repopulating” the committee, the HHS ...

After enduring multiple rounds of layoffs last year, Genentech’s employees are facing more uncertainty as the Roche unit lets ...